QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
QQQ   264.16 (-3.05%)
AAPL   107.12 (-4.19%)
MSFT   200.59 (-3.29%)
FB   249.02 (-2.25%)
GOOGL   1,409.39 (-3.45%)
AMZN   2,999.86 (-4.13%)
NVDA   484.95 (-4.07%)
TSLA   380.36 (-10.34%)
BABA   272.95 (-0.85%)
CGC   14.60 (-8.98%)
GE   6.11 (-2.24%)
MU   49.85 (+0.30%)
AMD   74.73 (-3.82%)
T   27.87 (-2.24%)
F   6.64 (-2.06%)
ACB   5.17 (-29.37%)
GILD   63.09 (-0.49%)
NFLX   470.61 (-4.19%)
DIS   123.28 (-3.09%)
BAC   23.26 (-2.84%)
BA   151.18 (-3.58%)
Log in
NASDAQ:CBAY

CymaBay Therapeutics SEC Filings & 10K Form

$6.23
-0.31 (-4.74 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.17
Now: $6.23
$6.86
50-Day Range
$5.25
MA: $6.20
$6.92
52-Week Range
$1.21
Now: $6.23
$7.09
Volume1.20 million shs
Average Volume2.87 million shs
Market Capitalization$429.17 million
P/E RatioN/A
Dividend YieldN/A
Beta1.72

SEC Filings

CymaBay Therapeutics (NASDAQ:CBAY) SEC Filings

DateFilerForm TypeView
09/01/2020
11:25 AM
Avoro Capital Advisors LLC (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G
08/28/2020
10:15 AM
CymaBay Therapeutics (Filer)
Form CT ORDER
08/10/2020
3:02 PM
CymaBay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2020
9:00 AM
Aghazadeh Behzad (Reporting)
Avoro Capital Advisors LLC (Reporting)
CymaBay Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/14/2020
3:13 PM
CymaBay Therapeutics (Filer)
Form 424B5
07/14/2020
3:12 PM
CymaBay Therapeutics (Filer)
Form 424B5
07/13/2020
11:15 PM
CymaBay Therapeutics (Filer)
Form EFFECT
05/19/2020
4:23 PM
CymaBay Therapeutics (Issuer)
von Emster Kurt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:22 PM
CymaBay Therapeutics (Issuer)
TRUEX PAUL F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:20 PM
CymaBay Therapeutics (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:19 PM
CymaBay Therapeutics (Issuer)
Wills Robert James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:17 PM
CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:16 PM
CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
8:00 AM
CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
Form SC 13D/A
05/11/2020
4:15 PM
CymaBay Therapeutics (Filer)
Form DEFA14A
05/11/2020
3:08 PM
CymaBay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
3:02 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2020
1:50 PM
CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
Form PRRN14A
04/27/2020
3:42 PM
CymaBay Therapeutics (Subject)
Form PREC14A
04/24/2020
3:50 PM
CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
Form PREC14A
03/13/2020
4:29 PM
CymaBay Therapeutics (Filer)
Form DEFA14A
02/14/2020
4:02 PM
CymaBay Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/14/2020
3:26 PM
CymaBay Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2020
12:13 PM
CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
Form SC 13D/A
02/14/2020
9:21 AM
Avoro Capital Advisors LLC (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G
02/11/2020
3:44 PM
CymaBay Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/05/2020
10:45 AM
BlackRock Inc. (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G/A
01/29/2020
3:19 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
3:46 PM
CymaBay Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
12/19/2019
4:25 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2019
1:32 PM
CymaBay Therapeutics (Subject)
Newtyn Management, LLC (Filed by)
Form SC 13G
12/12/2019
4:04 PM
CymaBay Therapeutics (Subject)
ENGINE CAPITAL, L.P. (Filed by)
Form SC 13D
10/15/2019
7:20 AM
CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
7:56 AM
CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
3:44 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:03 PM
CymaBay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
6:01 PM
CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
5:57 PM
CymaBay Therapeutics (Issuer)
Dorling Janet (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2019
4:04 PM
CymaBay Therapeutics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
06/14/2019
3:05 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:02 PM
CymaBay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
3:07 PM
CymaBay Therapeutics (Filer)
Form DEF 14A
03/11/2019
7:30 AM
CymaBay Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
03/06/2019
3:27 PM
CymaBay Therapeutics (Filer)
Form 424B5
03/05/2019
3:51 PM
CymaBay Therapeutics (Filer)
Form 424B5
02/28/2019
3:07 PM
CymaBay Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2019
3:02 PM
CymaBay Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G/A
02/13/2019
12:51 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G/A
02/13/2019
12:00 PM
CymaBay Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
Form SC 13G/A
02/13/2019
10:50 AM
CymaBay Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/11/2019
11:15 PM
CymaBay Therapeutics (Filer)
Form EFFECT
02/08/2019
7:21 PM
CymaBay Therapeutics (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:07 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2019
4:30 PM
CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:29 PM
CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:29 PM
CymaBay Therapeutics (Issuer)
Quinlan Paul T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:28 PM
Boudes Pol F (Reporting)
CymaBay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:27 PM
CymaBay Therapeutics (Issuer)
McWherter Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:26 PM
CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:24 PM
CymaBay Therapeutics (Issuer)
Wills Robert James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:23 PM
CymaBay Therapeutics (Issuer)
Weiland Robert J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:22 PM
CymaBay Therapeutics (Issuer)
TRUEX PAUL F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:22 PM
CymaBay Therapeutics (Issuer)
STEIN EVAN A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:21 PM
CymaBay Therapeutics (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:20 PM
CymaBay Therapeutics (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:19 PM
Booth Robert F. (Reporting)
CymaBay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
4:15 PM
CymaBay Therapeutics (Issuer)
Dickinson Klara (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2019
4:04 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
3:06 PM
CymaBay Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/21/2018
4:11 PM
CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2018
3:18 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
3:02 PM
CymaBay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2018
7:00 AM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
5:21 AM
CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
6:24 PM
CymaBay Therapeutics (Issuer)
Menold Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
4:02 PM
CymaBay Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2018
3:02 PM
CymaBay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2018
5:05 AM
CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2018
8:00 AM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
8:59 AM
CymaBay Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
06/11/2018
7:42 AM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4/A
06/07/2018
6:30 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
3:11 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
7:08 AM
CymaBay Therapeutics (Issuer)
Shah Sujal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2018
3:26 PM
CymaBay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2018
3:24 PM
CymaBay Therapeutics (Filer)
Form DEFA14A
04/20/2018
3:19 PM
CymaBay Therapeutics (Filer)
Form DEF 14A
03/23/2018
3:56 PM
CymaBay Therapeutics (Issuer)
GOLDFISCHER CARL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
3:22 PM
CymaBay Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/15/2018
3:17 PM
CymaBay Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2018
3:19 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2018
3:08 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2018
1:44 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4/A
02/15/2018
3:12 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2018
2:02 PM
Abingworth LLP (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G/A
02/13/2018
3:19 PM
BAKER BROS. ADVISORS LP (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G
02/13/2018
2:45 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
CymaBay Therapeutics (Subject)
Form SC 13G/A
02/13/2018
11:28 AM
CymaBay Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
Form SC 13G/A
02/12/2018
3:09 PM
CymaBay Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.